Assoc. Prof. MD. Abdilkerim Oyman

Education and Specialization

• 2002–2008: Trakya University Faculty of Medicine, Medical Doctor (MD)

• 2022–2023: University of Health Sciences, Ümraniye Training and Research Hospital, Associate Professor

Experience

• 2010–2014: Trakya University Faculty of Medicine Hospital, Internal Medicine Clinic

• 2015–2018: Kartal Dr. Lütfi Kırdar Training and Research Hospital, Medical Oncology

• 2018–2023: University of Health Sciences, Ümraniye Training and Research Hospital, Medical Oncology

• 2023–Present: Private Gaziosmanpaşa Hospital

Languages

• English

Courses and Certificates

• Turkish Society of Medical Oncology (TSMO) Board Certification

• Basic Good Clinical Practice (GCP) Certificate

Professional Memberships

• Turkish Society of Medical Oncology (TTOD)

• European Society for Medical Oncology (ESMO)

• American Society of Clinical Oncology (ASCO)

Articles Published in International Peer-Reviewed Journals

• Karhan Oğur, İleri Serdar, Urakçı Zuhat, et al. (2025). Comparison Of The Efficacy Of Mfolfox-6 And Mdcf Regimens In The Treatment Of Metastatic Gastric Cancer: A Multicenter Retrospective Study. Therapeutic Advances In Medical Oncology, 17(1).

• Karaçin Cengiz, Çakmak Öksüzoğlu Ömür Berna, Demirci Ayşe, et al. (2023). Efficacy Of Subsequent Treatments In Patients With Hormone-Positive Advanced Breast Cancer Who Had Disease Progression Under Cdk 4/6 Inhibitor Therapy. Bmc Cancer, 23.

• Koca Sinan, Koca Esra, Ökten İlker Nihat, et al. (2022). Psychological Impacts Of Covid-19 Pandemic In Cancer Patients On Active Treatment. Heliyon, 8(8), 1-9.

• Erol Cihan, Şendur Mehmet Ali Nahit, Bilgetekin İrem, et al. (2022). Efficacy And Safety Of Folfiri Plus Aflibercept In Second-Line Treatment Of Metastatic Colorectal Cancer: Real-Life Data From Turkish Oncology Group. Journal Of Cancer Research And Therapeutics, 18(2), 347-353.

• Başoğlu Tüylü Tuğba, Sakin Abdullah, Erol Cihan, et al. (2022). Real Life Experience Of Patients With Locally Advanced Gastric And Gastroesophageal Junction Adenocarcinoma Treated With Neoadjuvant Chemotherapy: A Turkish Oncology Group Study. Journal Of Chemotherapy, 35(2), 142-149.

• Oyman Abdilkerim, Özçelik Melike, Çil İbrahim (2022). Impact Of Breast Cancer Subtypes On Pathological Complete Response Following Neoadjuvant Chemotherapy. Eurasian Journal Of Medical Investigation, 6(2), 147-150.

• Çil İbrahim, Küçükarda Ahmet, Atcı Muhammed Mustafa, et al. (2022). Efficacy And Safety Of Trastuzumab Emtansine In Older Patients With Her2-Positive Advanced Breast Cancer: A Real-World Study. Tumori Journal, 108(1), 19-25.

• Oyman Abdilkerim, Çil İbrahim, Özçelik Melike, et al. (2022). Evaluation Of Lipi And Mgps As Prognostic Factors In Extensive-Stage Small-Cell Lung Cancer. Journal Of Surgery And Medicine, 6(2), 115-119.

• Oyman Abdilkerim, Işık Selver, Eröz Seda, et al. (2022). The Effect Of Preoperative Prognostic Nutritional Index On Outcome In Glioblastoma Multiforme Patients. Journal Of Surgery And Medicine, 6(2), 177-180.

• Oyman Abdilkerim, Özçelik Melike, Başak Mustafa, et al. (2022). First-Line Pazopanib In Metastatic Renal Cell Carcinoma: Multicenter Experience. Journal Of Buon, 26(6), 2581-2586.

• Erol Cihan, Sakin Abdullah, Başoğlu Tüylü Tuğba, et al. (2022). Prognostic Factors Of Perioperative Flot Regimen In Operable Gastric And Gastroesophageal Junction Tumors: Real-Life Data (Turkish Oncology Group). Turkish Journal Of Medical Sciences, 52.

• Özçelik Melike, Oyman Abdilkerim, Çil İbrahim, et al. (2021). Cytoreductive Surgery Versus Systemic Chemotherapy Alone In Isolated Peritoneal Carcinomatosis Of Colorectal Origin. Journal Of The College Of Physicians And Surgeons Pakistan, 31(11), 1308-1313.

• Çil İbrahim, Oyman Abdilkerim, Işık Selver, et al. (2021). Prognostic Factors In Resected Biliary Tract Cancers And The Impact Of Cytokeratin 20 Expression. Journal Of Oncological Sciences, 7(3), 125-132.

• Oyman Abdilkerim, Başak Mustafa, Özçelik Melike, et al. (2021). Efficacy Of Abiraterone Acetate In Castration-Resistant Metastatic Prostate Cancer: A Real-World Data Analysis. Asia-Pacific Journal Of Clinical Oncology, 17(5), 201-207.

• Kuş Tülay, Aktaş Gökmen, Özçelik Melike, et al. (2021). Association Of Illness Perception With Chemotherapy-Induced Nausea And Vomiting: A Turkish Oncology Group (Tog) Study. Future Oncology, 17(15), 1933-1942.

• Oyman Abdilkerim, Başak Mustafa (2021). Primary Signet-Ring Cell Carcinoma Of Colorectal Origin: A Poor Prognostic Entity. Eurasian Journal Of Medical Investigation, 5(2), 213-217.

• Oyman Abdilkerim, Başak Mustafa, Özçelik Melike, et al. (2021). Clinical Outcomes Of Kaposi's Sarcoma Treated With Systemic Chemotherapy. Eurasian Journal Of Medical Investigation, 5(1), 12-15.

• Tataroğlu Özyükseler Deniz, Başak Mustafa, Ay Ersoy Seval, et al. (2020). Prognostic Factors Of Ado-Trastuzumab Emtansine Treatment In Patients With Metastatic Her-2 Positive Breast Cancer. Journal Of Oncology Pharmacy Practice, 27(3), 547-554.

• Özçelik Melike, Ercelep Özlem, Hallaç Keser Sevinç, et al. (2020). Ptk-7 Expression In Gastric Cancer: A Prognostic Determinant. Balkan Medical Journal, 37(2), 91-97.

• Aydın Dinçer, Şendur Mehmet Ali Nahit, Kefeli Umut, et al. (2017). Evaluation Of Bevacizumab In Advanced Small Bowel Adenocarcinoma. Clinical Colorectal Cancer, 16(1), 78-83.

• Özçelik Melike, Odabaş Hatice, Ercelep Özlem, et al. (2015). The Efficacy And Safety Of Capecitabine Plus Bevacizumab Combination As First-Line Treatment In Elderly Metastatic Colorectal Cancer Patients. Clinical And Translational Oncology, 18(6), 617-624.

Chapters in National/International Books

• Drug Interactions and Side Effects of Targeted Agents, Chapter Title: (Monoclonal Antibody Agents Blocking Egfr/Her (Cetuximab, Panitumumab, Trastuzumab, Pertuzumab, Nimotuzumab, Matuzumab)) (2021). Oyman Abdilkerim, Özçelik Melike, Türkiye Klinikleri, Editor: Aliustaoğlu Mehmet.

• Current Treatment Approaches in Oncology 1, Chapter Title: (Thymoma and Thymic Carcinomas) (2019). Oyman Abdilkerim, Akademisyen Yayınevi, Editors: Köse Fatih, Sedef Ali Murat.

• Breast Cancer, Chapter Title: (Chemoprevention in Breast Cancer) (2019). Oyman Abdilkerim, Akademisyen Yayınevi, Editors: Özyılkan Özgür, Sedef Ali Murat, et al.

Articles Published in National Peer-Reviewed Journals

• Ocak Birol, Şahin Ahmet Bilgehan, Ertürk İsmail, et al. (2024). Can Cytoreductive Nephrectomy Improve Outcomes Of Nivolumab Treatment In Patients With Metastatic Clear-Cell Renal Carcinoma? Current Oncology, 31(9), 5195.

• Özçelik Melike, Yaprak Gökhan, Gemici Cengiz, et al. (2022). Impact Of Diabetes On Clinical Outcomes Of Prostate Cancer. Eurasian Journal Of Medical Advances (Ejma), 2(3), 100-104.

• Oyman Abdilkerim, Ünsal Gülbin, Aydoğdu Nurettin, Usta Ufuk (2022). Protective Effects Of Silymarin On Acetaminophen-Induced Toxic Hepatitis. Eurasian Journal Of Medical Advances, 2(1), 1-6.

• Oyman Abdilkerim, Odabaş Hatice, Özçelik Melike (2021). Characteristics And Clinical Outcome Of Pt1a-B Node-Negative Breast Cancer. Northern Clinics Of Istanbul, 8(2), 124-129.